BioSpace News Archive

Business

Elanco Announces Global Agreement with Ab E Discovery for New Technology

Developed at the University of Wisconsin-Madison by Drs. Mark Cook and Jordan Sand, this unique innovation targets anti-nutritional challenges found in an animal’s gut.

January 25, 2018
·
3 min read
Drug Development

Juntendo University Research: Cognitive Neuroscience: the Awareness of Ignorance

Monkeys were presented with a metacognition task composed of a memory and a bet stage.

January 25, 2018
·
6 min read
Business

Myriad to Announce Fiscal Second-Quarter 2018 Financial Results on February 6, 2018

During the call, Mark C. Capone, president and CEO and Bryan Riggsbee, CFO, will provide an overview of Myriad’s financial performance for the fiscal second-quarter and provide a business update.

January 25, 2018
·
2 min read
Drug Development

Orphazyme: Publication of Manuscript Related to Phase II Trial Results for Arimoclomol in Patients With SOD1 ALS

The manuscript highlights arimoclomol’s favorable safety profile and provides data on efficacy that supports the continued development of arimoclomol in a Phase II/III trial.

January 25, 2018
·
3 min read
Biotech Bay

Autonomic Technologies Release: First Prospective Registry in SPG Stimulation Demonstrates Pulsante Therapy Effectively Treats Painful, Disabling Cluster Headaches

Autonomic Technologies, today announced the publication of results from the Pathway R-1 Registry study demonstrating the Pulsante SPG Microstimulator System’s effectiveness in more than two-thirds of patients with cluster headache, a disabling neurological condition with no known cure.

January 25, 2018
·
4 min read
Bio NC

Paragon International, Lnc. Launches New Brand, New Logo; Changes Corporate Name

Paragon International, Inc., a leading provider of clinical trial support services, today announced it has changed its name to Paragon Global CRS

January 25, 2018
·
2 min read
Business

Applied DNA Awarded Multi-Year Contract to Develop Molecular Tracking Systems for Legal Cannabis Worldwide

Applied DNA Sciences, Inc. today announced the signing of an initial two-year, $1 million contract with TheraCann International Benchmark Corporation.

January 25, 2018
·
6 min read
Business

Orexo: Full Year Report Incl. Q4 2017

Total net revenues SEK 191.0 million (184.7).

January 25, 2018
·
5 min read
Business

GenSight Biologics Appoints Julio Benedicto as Vice President of Marketing

Mr. Benedicto brings over 20 years of experience as a strategy consultant in life sciences, both in Europe and the United States.

January 25, 2018
·
3 min read
Business

Synpromics Announces New Partnership with UCL to Develop Novel Gene Therapies for Blood-Based Disorders

This new partnership further expands Synpromics’ activities in the cell and gene therapy sector, as it builds on its strategy of establishing partnerships with leading academics in the UK to integrate its technology into the next generation of gene-based medicines.

January 25, 2018
·
4 min read